Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
The phase 3 trial results CagriSemas Phase 3 evidence comes from the REDEFINE programme: four large trials run by Novo Nordisk in different populations
In recent years, an increasing number of studies have shown that elucidating the urate transporters is essential to address the balance of urate homeostasis and hyperuricaemia-related diseases
Ten months earlier, the Phase 3 Exenatide-PD3 trial had reached the same conclusion in Parkinsons disease: no effect on progression across 194 patients followed for 96 weeks, with no treatment difference on dopamine-transporter imaging in the trials imaging substudy [2]
Reprod Biol endocrinology
Our free calculators are designed to make that terminology easier to understand
doi:10.1093/clinchem/hvaa224 42
US$ 23.18
US$ 25.96
US$ 29.23
US$ 28.81
US$ 26.57
